ARCHIVES

NCAB Seeks Greater flexibility In Grants Target To Aid P01s

This article is from The Cancer Letter archive.

Vol. 17 No. 22 | May 31, 1991

Download PDF Visit The Full Archive

Related Articles

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

December 27, 2002

Rogers Bill Would Authorize $937 Million For NCI In ‘78

March 4, 1977

Program Announcements. RAPID Program Date Change.

June 29, 2001

New Treatment For CML Could Be Model for Molecular Target-Based Therapeutics

December 10, 1999

In Brief: OSCC Staff Appointments Announced Report Available On Chemical Disposal Health Aspects

August 3, 1984

Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin

July 23, 2010